Reveal new connections in complex disease

Reach further with NGS and array solutions

Complex Disease Genomics

Complex diseases affect us all. Illumina is committed to advancing our understanding of complex diseases and how they will be diagnosed and treated.

Complex diseases result from a combination of genetic and environmental factors, many of which are not understood. These diseases include neurodegenerative diseases, psychiatric, autoimmune disorders, and others.

Illumina's expanding complex disease product portfolio includes array and next-generation sequencing (NGS) technologies that are helping drive a revolution in complex disease genomics. Complete solutions deliver high-quality, reproducible results that accelerate research in various complex diseases. These discoveries have the potential to lead to life-changing improvements for patients and their loved ones.

Array and NGS soultions for Complex Disease Genomics

Illumina has microarray and NGS solutions to advance complex disease research in all focus areas, from immunology to neuroscience and beyond.

Immunology Research
Neuroscience Research
Other Complex Disease Research
See All

Illumina has genomic solutions for all levels of complex disease research, from large-scale genomic discovery to functional cellular, and clinical research.

Cellular Research
Clinical Complex Disease Research
High-Throughput Genomics Research
See All
Celebrate the Genome

We are at a tipping point in genomics, where scientists and researchers continue to translate the power of the genome from science to discoveries and applications. We encourage you to take a moment to reflect what the power of the genome means for complex diseases and share it. Educate others. Promote the promise of the genome.

Learn More
Give the Genome a Voice
Interested in receiving newsletters, case studies, and information on complex disease genomics? Please enter your email address.